Catalent plant in Indiana making Novo’s Wegovy, Reuters reports

Catalent’s plant in Bloomington, Indiana, will fill injection pens for Novo Nordisk’s (NVO) weight-loss drug Wegovy as part of the two companies’ expanded supply agreement, two sources familiar with the matter told Reuters, reports Maggie Fick. Reuters says Novo is spending billions of dollars to make more of its obesity drug amid sky-rocketing demand, particularly in the United States.